| Literature DB >> 28163016 |
Rhushikesh A Kulkarni1, Andrew J Worth2, Thomas T Zengeya1, Jonathan H Shrimp1, Julie M Garlick1, Allison M Roberts1, David C Montgomery1, Carole Sourbier3, Benjamin K Gibbs3, Clementina Mesaros2, Yien Che Tsai4, Sudipto Das5, King C Chan5, Ming Zhou5, Thorkell Andresson5, Allan M Weissman4, W Marston Linehan3, Ian A Blair2, Nathaniel W Snyder6, Jordan L Meier7.
Abstract
Non-enzymatic protein modification driven by thioester reactivity is thought to play a major role in the establishment of cellular lysine acylation. However, the specific protein targets of this process are largely unknown. Here we report an experimental strategy to investigate non-enzymatic acylation in cells. Specifically, we develop a chemoproteomic method that separates thioester reactivity from enzymatic utilization, allowing selective enrichment of non-enzymatic acylation targets. Applying this method to cancer cell lines identifies numerous candidate targets of non-enzymatic acylation, including several enzymes in lower glycolysis. Functional studies highlight malonyl-CoA as a reactive thioester metabolite that can modify and inhibit glycolytic enzyme activity. Finally, we show that synthetic thioesters can be used as novel reagents to probe non-enzymatic acylation in living cells. Our studies provide new insights into the targets and drivers of non-enzymatic acylation, and demonstrate the utility of reactivity-based methods to experimentally investigate this phenomenon in biology and disease. Published by Elsevier Ltd.Entities:
Keywords: Warburg effect; acetylation; acylation; epigenetics; glycolysis; malonylation; metabolism; non-enzymatic; reactivity-based protein profiling; thioester
Mesh:
Substances:
Year: 2017 PMID: 28163016 PMCID: PMC5864104 DOI: 10.1016/j.chembiol.2017.01.002
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116